Related references
Note: Only part of the references are listed.Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Reinforcement enhancement by nicotine in adult rats: behavioral selectivity and relation to mode of delivery and blood nicotine levels
Annie Constantin et al.
PSYCHOPHARMACOLOGY (2018)
Enhancement of a visual reinforcer by D-amphetamine and nicotine in adult rats: relation to habituation and food restriction
Jennifer M. Wright et al.
PSYCHOPHARMACOLOGY (2018)
A behavioral economic analysis of the value-enhancing effects of nicotine and varenicline and the role of nicotinic acetylcholine receptors in male and female rats
Scott T. Barrett et al.
BEHAVIOURAL PHARMACOLOGY (2018)
The contribution of agonist and antagonist activities of α4β2*nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data
Hans Rollema et al.
PSYCHOPHARMACOLOGY (2018)
Sex differences and the role of dopamine receptors in the reward-enhancing effects of nicotine and bupropion
Scott T. Barrett et al.
PSYCHOPHARMACOLOGY (2017)
Nicotine Acutely enhances Reinforcement from Non-Drug Rewards in Humans
Kenneth A. Perkins et al.
FRONTIERS IN PSYCHIATRY (2017)
Intravenous Nicotine Self-Administration in Smokers: Dose-Response Function and Sex Differences
Kevin P. Jensen et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Nicotine enhancement and reinforcer devaluation: Interaction with opioid receptors
Ari P. Kirshenbaum et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2016)
Reinforcer devaluation as a consequence of acute nicotine exposure and withdrawal
Ari Kirshenbaum et al.
PSYCHOPHARMACOLOGY (2015)
Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats
Elizabeth G. Guy et al.
BEHAVIOURAL PHARMACOLOGY (2014)
Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT2C receptor agonist but not by a 5-HT2A receptor antagonist
Elizabeth Glenn Guy et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
The incentive amplifying effects of nicotine are reduced by selective and non-selective dopamine antagonists in rats
Matthew I. Palmatier et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Nicotine-induced enhancement of responding for conditioned reinforcement in rats: Role of prior nicotine exposure and α4β2 nicotinic receptors
Elizabeth Glenn Guy et al.
PSYCHOPHARMACOLOGY (2013)
α- and β-Adrenergic Receptors Differentially Modulate the Emission of Spontaneous and Amphetamine-Induced 50-kHz Ultrasonic Vocalizations in Adult Rats
Jennifer M. Wright et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Varenicline Dose Dependently Enhances Responding for Nonpharmacological Reinforcers and Attenuates the Reinforcement-Enhancing Effects of Nicotine
Melissa E. Levin et al.
NICOTINE & TOBACCO RESEARCH (2012)
Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice
K. M. Tobey et al.
PSYCHOPHARMACOLOGY (2012)
A second-order schedule of food reinforcement in rats to examine the role of CB1 receptors in the reinforcement-enhancing effects of nicotine
Victoria C. Wing et al.
ADDICTION BIOLOGY (2010)
Noradrenergic α1 Receptors as a Novel Target for the Treatment of Nicotine Addiction
Benoit Forget et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats
Naila Ismayilova et al.
PSYCHOPHARMACOLOGY (2010)
Reinforcing effects of nicotine and non-nicotine components of cigarette smoke
Jed E. Rose et al.
PSYCHOPHARMACOLOGY (2010)
The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine
Neil E. Paterson
BEHAVIOURAL PHARMACOLOGY (2009)
Rats Self-Administer Intravenous Nicotine Delivered in a Novel Smoking-Relevant Procedure: Effects of Dopamine Antagonists
Robert E. Sorge et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of α4β2 nicotinic receptors in rats
Krista Spiller et al.
NEUROPHARMACOLOGY (2009)
Facilitation of intravenous nicotine self-administration in rats by a motivationally neutral sensory stimulus
Robert E. Sorge et al.
PSYCHOPHARMACOLOGY (2009)
Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats
Matthew I. Palmatier et al.
PSYCHOPHARMACOLOGY (2009)
Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration-comparison with CB1 receptor blockade
Benoit Forget et al.
PSYCHOPHARMACOLOGY (2009)
Disrupting Nicotine Reinforcement From Cigarette to Brain
Jed E. Rose
ADDICTION REVIEWS 2008 (2008)
A demonstration of intravenous nicotine self-administration in humans?
Heather G. Fulton et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine
Matthew I. Palmatier et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats
Xiu Liu et al.
PSYCHOPHARMACOLOGY (2007)
The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions
Arlene C. Pak et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers
M Palmatier et al.
PSYCHOPHARMACOLOGY (2006)
The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors
JG Baker
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Naltrexone attenuates acute cigarette smoking behavior
AM Epstein et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Nicotine enhances responding with conditioned reinforcement
P Olausson et al.
PSYCHOPHARMACOLOGY (2004)
Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A
J De Vry et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement
EC Donny et al.
PSYCHOPHARMACOLOGY (2003)
Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole.: A new class of highly selective α1 adrenoceptor antagonists
T Balle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
C Cohen et al.
BEHAVIOURAL PHARMACOLOGY (2002)
Environmental stimuli promote the acquisition of nicotine self-administration in rats
AR Caggiula et al.
PSYCHOPHARMACOLOGY (2002)
Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats
AA Harrison et al.
PSYCHOPHARMACOLOGY (2002)
SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats
V Deroche-Gamonet et al.
PSYCHOPHARMACOLOGY (2001)
Share Paper
